Signaling pathways
-
BA8803 FlumatinibSummary: Flumatinib is a selective inhibitor with oral activity. -
BA8804 VodobatinibSummary: Vodobatinib (K0706) is a potent third-generation, and orally active, tyrosine kinase inhibitor. -
BA8805 SIAIS178Summary: SIAIS178 is a class of effective, selective degradation agents. -
BA8807 BCR-ABL-IN-8Summary: An inhibitor containing trimethoxy (trimethoxygroup). -
BA8809 AKE-72Summary: AKE-72 is a potent inhibitor. -
BA8810 HG-7-86-01Summary: HG-7-86-01 is a type II tyrosine kinase inhibitor. -
BA8811 CHMFL-BMX-078Summary: CHMFL-BMX-078 is a potent, selective, irreversible, type II kinase inhibitor. -
BA8812 TilfrinibSummary: Tilfrinib is a potent and selective inhibitor. -
BA8813 SB-633825Summary: SB-633825 is a potent, ATP-competitive inhibitor. -
BA8814 XMU-MP-2Summary: XMU-MP-2 is an inhibitor with significant inhibitory activity against BRK-positive cells.

